NON-ENFORCEMENT
HHS says it is easing peptide access; FDA scientists say it is ordering the gate left open.
Source article: Most FDA scientists reportedly oppose HHS plan to ease peptide access.
Column metadata
- Published
- Pen name
- Editorial Board
- Topic tags
- health
- Primary entities
- U.S. Food and Drug Administration, Department of Health and Human Services, Robert F. Kennedy Jr., White House, Alliance for Pharmacy Compounding
- Themes
- FDA regulation of unproven peptide drugs, Compounding pharmacy enforcement, Drug safety review, White House policy review
- Floor values engaged
- human_life_and_dignity, Accountability of power, Truthfulness